Abnova (Taiwan) Corporation — Investor Relations & Filings
Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司新任第四屆薪資報酬委員會委員 | 2020-07-01 | Chinese | |
| 公告本公司董事會決議除息基準日及現金股利發放日 | 2020-07-01 | Chinese | |
| 109年年報及股東會資料 — 2020_4133_20200617F05.pdf | 2020-06-29 | Chinese | |
| 109年年報及股東會資料 — 2020_4133_20200617F17.pdf | 2020-06-29 | Chinese | |
| 109年年報及股東會資料 — 2019_4133_20200617F04.pdf | 2020-06-29 | Chinese | |
| 109年年報及股東會資料 — 2020_4133_20200617F02.pdf | 2020-06-29 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 34540828 | 公告本公司新任第四屆薪資報酬委員會委員 | 2020-07-01 | Chinese | ||
| 34540832 | 公告本公司董事會決議除息基準日及現金股利發放日 | 2020-07-01 | Chinese | ||
| 34545883 | 109年年報及股東會資料 — 2020_4133_20200617F05.pdf | 2020-06-29 | Chinese | ||
| 34545869 | 109年年報及股東會資料 — 2020_4133_20200617F17.pdf | 2020-06-29 | Chinese | ||
| 34545865 | 109年年報及股東會資料 — 2019_4133_20200617F04.pdf | 2020-06-29 | Chinese | ||
| 34545848 | 109年年報及股東會資料 — 2020_4133_20200617F02.pdf | 2020-06-29 | Chinese | ||
| 34545841 | 109年年報及股東會資料 — 2020_4133_20200617F13.pdf | 2020-06-29 | Chinese | ||
| 34545839 | 109年年報及股東會資料 — 2020_4133_20200617F01.pdf | 2020-06-29 | Chinese | ||
| 34540837 | 公告本公司法人董事代表人變更 | 2020-06-19 | Chinese | ||
| 34540846 | 公告本公司新任第三屆審計委員會委員 | 2020-06-17 | Chinese | ||
| 34540850 | 公告本公司第三屆薪資報酬委員會委員任期屆滿 | 2020-06-17 | Chinese | ||
| 34540853 | 本公司董事會推舉Wilber Huang先生續任董事長 | 2020-06-17 | Chinese | ||
| 34540858 | 公告本公司109年股東常會決議通過解除新任董事及其代表人 競業禁止事宜 | 2020-06-17 | Chinese | ||
| 34540863 | 公告本公司109年股東常會全面改選董事當選名單 | 2020-06-17 | Chinese | ||
| 34540866 | 公告本公司109年股東常會重要決議事項 | 2020-06-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
Abnova (Taiwan) Corporation via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52384/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52384 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52384 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52384 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52384}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abnova (Taiwan) Corporation (id: 52384)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.